Heterogeneous Catalytic Ozonation of Pharmaceuticals: Optimization of the Process by Response Surface Methodology.

Batch heterogeneous catalytic ozonation experiments were performed using commercial and synthesized nanoparticles as catalysts in aqueous ozone. The transferred ozone dose (TOD) ranged from 0 to 150 μM, and nanoparticles were added in concentrations between 0 and 1.5 g L^-1, with all experiments conducted at 20 °C and a total volume of 240 mL. A Ce-doped TiO₂ catalyst (1% molar ratio of Ce/Ti) was synthesized via the sol-gel method. Response surface methodology (RSM) was applied to identify the most significant factors affecting the removal of selected pharmaceuticals, with TOD emerging as the most critical variable. Higher TOD resulted in greater removal efficiencies. Furthermore, it was found that the commercially available metal oxides α-Al₂O₃, Mn₂O₃, TiO₂, and CeO₂, as well as the synthesized CeTiO_x, did not increase the catalytic activity of ozone during the degradation of ibuprofen (IBF) and para-chlorobenzoic acid (pCBA). Carbamazepine (CBZ) and diclofenac (DCF) are compounds susceptible to ozone oxidation, thus their complete degradation at 150 μM transferred ozone dose was attained. The limited catalytic effect was attributed to the rapid consumption of ozone within the first minute of reaction, as well as the saturation of catalyst active sites by water molecules, which inhibited effective ozone adsorption and subsequent hydroxyl radical generation (^●OH).